Product Description
Geftib 250mg tablet is used to treat adults with non-small cell lung cancer (locally advanced or distance spread metastasis).How it works Geftib 250mg tablet blocks a protein called epidermal growth factor receptor (EGFR) which is involved in the growth and spread of cancer cells.Common side effects Nausea, Pancreatic inflammation, Liver inflammation, Bleeding, Dehydration, Diarrhoea, Difficulty in urination, Lung disorder, Fever, Hair loss, Increased bilirubin in the blood, Liver enzyme increased, Increased creatinine level in blood, Itching, Dry skin, Loss of appetite, Nail disorder, Eye redness, Eye itching, Sore eyelids, Eyelid redness, Skin reaction, Mouth ulcer, Skin redness, Vomiting, Weakness.
FAQs of Geftinat Tab:
Q: What is the recommended dosage for Geftinat Tab?
A: The recommended dosage for Geftinat Tab is 250MG.
Q: What is Geftinat Tab used for?
A: Geftinat Tab is recommended for the treatment of lung cancer.
Q: Who is Geftinat Tab suitable for?
A: Geftinat Tab is suitable for adults.
Q: What are the storage instructions for Geftinat Tab?
A: Geftinat Tab should be stored in a cool, dry place.
Q: What is the key ingredient in Geftinat Tab?
A: The key ingredient in Geftinat Tab is Gefitinib.